[{"address1": "3300 Nacogdoches Road", "address2": "Suite 216", "city": "San Antonio", "state": "TX", "zip": "78217", "country": "United States", "phone": "210 698 5334", "website": "https://www.bioaffinitytech.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.", "fullTimeEmployees": 57, "companyOfficers": [{"maxAge": 1, "name": "Mr. Steven  Girgenti", "age": 78, "title": "Founder & Executive Chairman of the Board", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 115430, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maria  Zannes J.D.", "age": 68, "title": "Founder, President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 327157, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Xavier T. Reveles M.S.", "age": 54, "title": "Chief Operating Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William  Bauta Ph.D.", "title": "Chief Science Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy P. Zannes J.D.", "age": 71, "title": "Executive VP, Secretary & General Counsel", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie Anne Overton", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dallas J. Coleman", "title": "Vice President of sales", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gordon  Downie M.D., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 3.41, "open": 6.2, "dayLow": 4.65, "dayHigh": 7.29, "regularMarketPreviousClose": 3.41, "regularMarketOpen": 6.2, "regularMarketDayLow": 4.65, "regularMarketDayHigh": 7.29, "payoutRatio": 0.0, "beta": 2.543, "forwardPE": -8.816667, "volume": 99562135, "regularMarketVolume": 99562135, "averageVolume": 1767427, "averageVolume10days": 10841575, "averageDailyVolume10Day": 10841575, "bid": 5.34, "ask": 6.75, "bidSize": 1, "askSize": 1, "marketCap": 7078173, "fiftyTwoWeekLow": 3.4, "fiftyTwoWeekHigh": 67.11, "allTimeHigh": 466.5, "allTimeLow": 3.4, "priceToSalesTrailing12Months": 0.92151004, "fiftyDayAverage": 7.864, "twoHundredDayAverage": 13.90345, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4837233, "profitMargins": -1.52179, "floatShares": 772296, "sharesOutstanding": 1338029, "sharesShort": 111016, "sharesShortPriorMonth": 32864, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.1126, "heldPercentInsiders": 0.18287, "heldPercentInstitutions": 0.01407, "shortRatio": 0.33, "shortPercentOfFloat": 0.1275, "impliedSharesOutstanding": 1338029, "bookValue": -2.274, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -11688941, "trailingEps": -17.1, "forwardEps": -0.6, "lastSplitFactor": "1:30", "lastSplitDate": 1758240000, "enterpriseToRevenue": 0.63, "enterpriseToEbitda": -0.51, "52WeekChange": -0.9152244, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 5.29, "recommendationKey": "none", "totalCash": 802835, "totalCashPerShare": 0.855, "ebitda": -9490369, "totalDebt": 669997, "quickRatio": 0.473, "currentRatio": 0.645, "totalRevenue": 7681059, "revenuePerShare": 13.658, "returnOnAssets": -1.10268, "returnOnEquity": -18.0245, "grossProfits": 2294273, "freeCashflow": -3465642, "operatingCashflow": -7675376, "revenueGrowth": -0.471, "grossMargins": 0.29869, "ebitdaMargins": -1.23555, "operatingMargins": -1.9815601, "financialCurrency": "USD", "symbol": "BIAF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "bioAffinity Technologies, Inc.", "exchange": "NCM", "messageBoardId": "finmb_423045573", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketTime": 1758916801, "regularMarketChangePercent": 55.132, "regularMarketPrice": 5.29, "marketState": "CLOSED", "postMarketTime": 1758931184, "longName": "bioAffinity Technologies, Inc.", "postMarketChangePercent": -9.262755, "postMarketPrice": 4.8, "postMarketChange": -0.48999977, "regularMarketChange": 1.88, "regularMarketDayRange": "4.65 - 7.29", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1767427, "fiftyTwoWeekLowChange": 1.8899999, "fiftyTwoWeekLowChangePercent": 0.5558823, "fiftyTwoWeekRange": "3.4 - 67.11", "fiftyTwoWeekHighChange": -61.82, "fiftyTwoWeekHighChangePercent": -0.92117417, "fiftyTwoWeekChangePercent": -91.52244, "earningsTimestampStart": 1755174600, "earningsTimestampEnd": 1755174600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -17.1, "epsForward": -0.6, "epsCurrentYear": -14.40001, "priceEpsCurrentYear": -0.36736086, "fiftyDayAverageChange": -2.574, "fiftyDayAverageChangePercent": -0.32731435, "twoHundredDayAverageChange": -8.61345, "twoHundredDayAverageChangePercent": -0.6195189, "priceToBook": -2.3262973, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-08-25", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1662039000000, "displayName": "bioAffinity", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]